Fundación Sanatorio Güemes
Buenos Aires, Argentina
General hospital in Buenos Aires
Francisco Acuña de Figueroa 1240, C1180 CABA
About Fundación Sanatorio Güemes
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Genfit
1
Nektar Therapeutics
1
Clinical Trials at Fundación Sanatorio Güemes
During the past decade, Fundación Sanatorio Güemes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
2016-03-01
2020-10-28
Terminated
2,157
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)
2018-12-18
2022-10-19
Terminated
623
A Study of Baricitinib (LY3009104) in Participants With COVID-19
2020-06-12
2021-06-10
Completed
1,525
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
2020-07-01
2021-10-08
Completed
278
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Fundación Sanatorio Güemes"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Fundación Sanatorio Güemes
According to Clinical.Site data, the most researched conditions in "Fundación Sanatorio Güemes" are
"COVID-19" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials), "Nonalcoholic Steatohepatitis (NASH) With Fibrosis" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Fundación Sanatorio Güemes" in a lesser frequency.
Clinical Trials Intervention Types at Fundación Sanatorio Güemes
Most popular intervention types in "Fundación Sanatorio Güemes" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Baricitinib" (1 trials), "Elafibranor" (1 trials), "Insulin Degludec" (1 trials) and "LY3209590" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fundación Sanatorio Güemes
The vast majority of trials in "Fundación Sanatorio Güemes" are
4 trials for "All" genders.
Clinical Trials Status at Fundación Sanatorio Güemes
Currently, there are NaN active trials in "Fundación Sanatorio Güemes".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Fundación Sanatorio Güemes,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Fundación Sanatorio Güemes, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".